^Glick SD, Haskew RE, Maisonneuve IM, Carlson JN, Jerussi TP (May 2000). "Enantioselective behavioral effects of sibutramine metabolites". European Journal of Pharmacology. 397 (1): 93–102. doi:10.1016/s0014-2999(00)00216-8. PMID10844103.
^Park SR, Lee JG, Roh SH, Kim G, Kwon CH, Park HR, et al. (2012). "Determination of PDE-5 inhibitors and appetite suppressants in adulterated dietary supplements using LC/PDA and LC/MS". Food Additives & Contaminants. Part B, Surveillance. 5 (1): 29–32. doi:10.1080/19393210.2012.656706. PMID24779692. S2CID21389290.
^Reeuwijk NM, Venhuis BJ, de Kaste D, Hoogenboom RL, Rietjens IM, Martena MJ (2014). "Active pharmaceutical ingredients detected in herbal food supplements for weight loss sampled on the Dutch market". Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment. 31 (11): 1783–1793. doi:10.1080/19440049.2014.958574. PMID25247833. S2CID24272967.
^Zeng Y, Xu Y, Kee CL, Low MY, Ge X (2016). "Analysis of 40 weight loss compounds adulterated in health supplements by liquid chromatography quadrupole linear ion trap mass spectrometry". Drug Testing and Analysis. 8 (3–4): 351–6. doi:10.1002/dta.1846. PMID26305055. S2CID47560433.
^Jeong D, Choe S, Lee S, Kim KM, Pyo J (January 2021). "Metabolic analysis of the illegal analogues of anti-obesity drugs using LC-Q-TOF-MS/MS". Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1163: 122502. doi:10.1016/j.jchromb.2020.122502. PMID33412503. S2CID231195145.